Search Results 171-180 of 7346 for infliximab

  1. Adalimumab-aqvh (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aqvh injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  2. Ulcerative Colitis Clinical Trials

    ... infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side ...

  3. Statins For The Treatment Of NASH - Mayo Clinic

    Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies (infliximab, adalimumab, etanercept) or anti-integrin therapy

  4. Adalimumab-adbm (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-adbm injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  5. A Study To Evaluate The Safety And Effectiveness Of Adult Allogeneic Expanded Adipose-derived Stem Cells (EASC) For The Treatment Of Complex Perianal Fistula(s) In Patients With Crohn's Disease - Mayo Clinic

    Infliximab: at least 14 weeks treatment at the approved doses for induction and/or maintenance in Crohn´s disease prior to screening for the study. For ...

  6. Ustekinumab-aekn (subcutaneous route) - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  7. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    In patients with Crohn's disease treated with infliximab, for example, there is a significant association between visceral, but not subcutaneous, fat adiposity ...

  8. Publications - Kristen B. McCullough, Pharm.D., R.Ph. - Mayo Clinic

    Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017 Sep; 23 ...

  9. A Study To Assess Whether Etrolizumab Is A Safe And Effective Treatment For Participants With Moderately To Severely Active Crohn's Disease (CD) - Mayo Clinic

    Initially responded to induction therapy with infliximab (≥ 5 mg/kg) or ... Infliximab. Any prior treatment with ustekinumab within 14 weeks prior to ...

  10. Publications - Melissa R. Snyder, Ph.D. - Mayo Clinic

    ... Infliximab and Adalimumab Without Acid Dissociation. ... Comparison of Clinical Laboratory Assays for Measuring Serum Infliximab and Antibodies to Infliximab.